FIELD: medicine.
SUBSTANCE: invention concerns determining a degree of severity of psychosomatic disorders in patients with discirculatory encephalopathy. That is ensured by a standard therapeutic, neurologic, instrumental examination. That is added with measuring primary anti-S100B protein antibody (AT) titres in blood serum. If the measured titre is up to 150, they should be taken into account in stating degree 3 discirculatory encephalopathy with cognitive disorders reaching moderate or severe dementia accompanied by severe affective and behavioural disorders.
EFFECT: higher specificity, accuracy, sensitivity and reliability of the molecular diagnostic technique.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR QUANTITATIVE MEASUREMENT OF DIFFERENTIATION FACTOR THAT IS PROGNOSTIC BIOMARKER OF NORMAL AND PATHOLOGICAL INDIVIDUAL'S VASCULAR SYSTEM | 2013 |
|
RU2532381C1 |
| DIAGNOSTIC METHOD OF SEVERITY DEGREE OF DIABETIC ENCEPHALOPATHY WITH CHILDREN AND TEENAGERS | 2008 |
|
RU2368905C1 |
| REAGENT FOR IMMUNOENZYME ANALYSIS AND METHOD OF IMMUNOENZYME TESTING OF SPECIFIC ANTIBODY IN OPISTHORCHIASIS CAUSED BY HEPATIC TREMATODE OPISTHORCHIS FELINEUS | 2001 |
|
RU2197736C1 |
| 0 |
|
SU1778184A1 | |
| STRAIN OF HYBRID CULTURED MAMMALIAN CELLS MUS MUSCULUS L - PRODUCER OF MONOCLONAL ANTIBODIES AGAINST PROTEIN P24 OF CATTLE LEUKOSIS VIRUS | 0 |
|
SU1627557A1 |
| METHOD OF EARLY DETECTION OF DIABETICAL ENCEPHALOPATHY IN CHILDREN | 2008 |
|
RU2389027C2 |
| METHOD FOR DETECTING ANTIBODIES TO SARS-CoV-2 IN MIXED SALIVA | 2022 |
|
RU2787171C1 |
| METHOD OF PRODUCING DIAGNOSTIC SERUM FOR DETECTING ALEUTIAN DISEASE OF MINK VIRUS | 2015 |
|
RU2592232C1 |
| METHOD OF DIFFERENTIATING VIRULENT LISTERIA MONOCYTOGENES STRAINS FROM AVIRULENT STRAINS USING POLYCLONAL ANTIBODIES AGAINST PATHOGENICITY FACTORS INTERNALIN A (INLA) AND INTERNALIN B (INLB) | 2023 |
|
RU2808590C1 |
| MONOCLONAL ANTI-IDIOTYPIC ANTIBODY AB2, METHOD FOR ITS PREPARING, USAGE AGAINST DISEASES ACCOMPANYING WITH EXPRESSION OF LEWIS Y6 ANTIGEN AND FOR PURIFICATION OF ANTIBODY VARIANT BR 55-2, CURATIVE-PROPHYLACTIC COMPOSITION | 1993 |
|
RU2208642C2 |
